• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Benzamycin Topical Gel
    / Perrigo


    Active Ingredient *
    Benzoyl Peroxide 87.125 mg/g
    Erythromycin 0.8 g

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Gel

    23.3 g

    not in the basket chart 9204 2053

    Related information


    Dosage

    BENZAMYCIN Topical Gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry.
    See prescribing information for full details.


    Indications

    Acne vulgaris.


    Contra-Indications

    Hypersensitivity to erythromycin, benzoyl peroxide or any of the other listed ingredients.


    Special Precautions

    Concomitant topical acne therapy should be used with caution especially with peeling desquamating or abrasive agents. For external use only. Avoid contact with the eyes and mucous membranes. Should not use any other topical acne preparation unless otherwise directed by physician. May bleach hair or colored fabric. Pregnancy and lactation: Should be given to pregnant women only if clearly needed. Caution should be exercised when administered to a nursing woman. Safety and effectiveness in children below the age of 12 have not been established.


    Side Effects

    Dryness, erythema and pruritus.
    See prescribing information for full details.


    Drug interactions

    Antagonism has been demonstrated in vitro between erythromycin, lincomycin, chloramphenicol and clindamycin.
    Therefore erythromycin, lincomycin, chloramphenicol and clindamycin should not be used concomitantly with Benzamycin, although no studies have been conducted testing for antagonism of Benzamycin with these antibiotics.


    Pregnancy and Lactation

    Pregnancy: There are no well-controlled trials in pregnant women with BENZAMYCIN Topical Gel. It also is not known whether BENZAMYCIN Topical Gel can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. BENZAMYCIN Topical Gel should be given to a pregnant woman only if clearly needed.
    Nursing Women: It is not known whether BENZAMYCIN Topical Gel is excreted in human milk after topical application. However, erythromycin is excreted in human milk following oral and parenteral erythromycin administration.
    Therefore, caution should be exercised when erythromycin is administered to a nursing woman.


    Manufacturer
    Valeany Canada LP / Valeany Canada S.E.C
    CLOSE